Date(s) - 29/05/2020 - 31/05/2020
12:00 am - 4:00 pm
Categories No Categories
Last Updated April 13, 2020
Join oncology professionals from around the world for the ASCO20 Virtual Scientific Program to see and hear the brightest minds in oncology presenting state-of-the-art treatment modalities and new therapies. The virtual meeting, to be held Friday, May 29, through Sunday, May 31, will provide an engaging lineup of scheduled and on-demand scientific content offering the opportunity to learn and collaborate across a variety of approaches, disciplines, and specialties.
While registration is required for all attendees, the ASCO20 Virtual Scientific Program meeting fees will be discounted for non-members and waived completely for ASCO members. Registration will open in late April, and attendees of the ASCO20 Virtual Scientific Program will also receive access to the ASCO20 Virtual Education Program, to be held in August, at no additional charge.
We have planned an exciting meeting and look forward to welcoming you virtually. On Friday May 29, all oral, poster, and poster discussion presentations, as well as track-based Clinical Science Symposia, will be available online. Over the weekend, we will host scheduled events, including the Opening Session featuring the Presidential Address by Howard A. “Skip” Burris III, MD and Guest Speaker Address by David Fajgenbaum, MD; the Plenary Session; cross-cutting Clinical Science Symposia; and track-specific highlight sessions featuring the top science and highest impact results in each area. Participants will be eligible to receive CME, MOC, and CE credit.
ASCO20 Virtual Scientific Program Schedule:
Wednesday, May 13: The majority of abstracts accepted for publication at the virtual meeting and for online publication will be released on schedule at 5:00 pm ET.
Friday, May 29: Oral, poster, and poster discussion sessions, as well as track-based Clinical Science Symposia, will be available on demand. Registrants will have exclusive access to hundreds of video and slide presentations, as well as discussant commentary for 180 days.
Saturday, May 30 (All sessions to be hosted in ET)
9:30 am: Opening Session with keynote address from ASCO President Howard A. “Skip” Burris III, MD and Guest Speaker Address by David Fajgenbaum, MD
10:30 am: Highlights Sessions: Breast Cancer; Head and Neck Cancer
11:00 am: Highlights Sessions: Gastrointestinal Cancers; Central Nervous System Tumors
11:30 am: Highlights Sessions: Hematological Malignancies; Gynecological Cancers
1:00 pm: Clinical Science Symposium: Harnessing Immunotherapy with Novel Approaches Beyond Checkpoint Inhibitors
2:30 pm: Highlights Sessions: Cancer Prevention, Risk Reduction, and Genetics; Symptoms and Survivorship
3:30 pm: Clinical Science Symposium: Redefining Cancer of Unknown Primary: Is Genomics the Answer?
Sunday, May 31 (All sessions to be hosted in ET)
9:30 am: Highlights Sessions: Melanoma; Health Services Research and Quality Improvement
10:00 am: Highlights Sessions: Lung Cancer; Pediatric Oncology
10:30 am: Clinical Science Symposium: Drug Development for Rare Mutations: The Opportunity to Unite and Conquer
1:00 pm: Plenary Session
3:30 pm: Highlights Sessions: Genitourinary Cancers; Sarcoma
4:00 pm: Highlights Sessions: Developmental Therapeutics; Care Delivery and Regulatory Policy
Watch for the full digital program – available on April 29th.
In addition, we will be hosting the ASCO20 Virtual Education Program in August 2020. Watch for more details in the coming weeks.
Please continue to check our regularly updated FAQs for additional details, and follow @ASCO on Twitter for real-time updates. Should you have any questions, please contact us at email@example.com.